Johnson & Johnson (JNJ) EBT (2009 - 2026)

Johnson & Johnson has disclosed EBT across 18 years of filings, most recently posting $6.0 billion for Q1 2026.

• EBT for Q1 2026 came in at $6.0 billion, down 56.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.9 billion (down 6.25% YoY), and the FY2025 annual result was $32.6 billion, up 95.25% from the prior year.
• EBT came in at $6.0 billion for Q1 2026 at Johnson & Johnson, up from $5.0 billion in the prior quarter.
• In the past five years, EBT ranged from a high of $13.6 billion in Q1 2025 to a low of -$1.3 billion in Q2 2023.
• The 5-year median for EBT is $5.2 billion (2022), against an average of $5.3 billion.
• Across the five-year window, EBT plunged 124.74% in 2023 and jumped 388.58% in 2024, its largest moves.
• Johnson & Johnson's EBT stood at $5.2 billion in 2022, then retreated by 6.69% to $4.8 billion in 2023, then dropped by 19.46% to $3.9 billion in 2024, then grew by 27.76% to $5.0 billion in 2025, then increased by 20.62% to $6.0 billion in 2026.
• The last three EBT figures came in at $6.0 billion (Q1 2026), $5.0 billion (Q4 2025), and $7.5 billion (Q3 2025), per Business Quant data.